Neuroactive steroid effects on cognitive functions with a focus on the serotonin and GABA systems

Brain Research Reviews

Volumn 51, Issue 2, 2006, Pages 212-239

  Birzniece, Vita ^a   Bäckström, Torbjörn ^a   Johansson, Inga Maj ^a   Lindblad, Charlotte ^a   Lundgren, Per ^a   Löfgren, Magnus ^a   Olsson, Tommy ^a   Ragagnin, Gianna ^a   Taube, Magdalena ^a   Turkmen, Sahruh ^a   Wahlström, Göran ^b   Wang, Ming De ^a   Wihlbäck, Anna Carin ^a   Zhu, Di ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

Allopregnanolone; Estradiol; GABAA receptor; Morris water maze; Progesterone; Serotonin receptor; UC1011

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; ANTIDEPRESSANT AGENT; BENZODIAZEPINE; CITALOPRAM; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; CYPROTERONE ACETATE; DIHYDROGESTERONE; ESTRADIOL; ESTROGEN; FLUOXETINE; FLURAZEPAM; FLUVOXAMINE; GESTAGEN; MIFEPRISTONE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROSTEROID; NOMEGESTROL; PAROXETINE; PINDOLOL; PROGESTERONE; SEROTONIN; SEROTONIN 1A AGONIST; SEROTONIN 2A ANTAGONIST; SEROTONIN 2C ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; STEROID RECEPTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALZHEIMER DISEASE; ANXIETY DISORDER; CENTRAL NERVOUS SYSTEM; COGNITION; GABAERGIC SYSTEM; HIPPOCAMPUS; HORMONE SYNTHESIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LEARNING; MAJOR DEPRESSION; MEMORY; MENSTRUAL CYCLE; MOOD CHANGE; NEUROTRANSMISSION; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PUERPERAL DEPRESSION; REVIEW; SEROTONINERGIC SYSTEM; SPATIAL MEMORY; STRUCTURE ANALYSIS; WELLBEING;

ANIMALS; BRAIN; COGNITION; COGNITION DISORDERS; GAMMA-AMINOBUTYRIC ACID; GONADAL STEROID HORMONES; HUMANS; LEARNING; NEURAL PATHWAYS; RECEPTORS, GABA-A; SEROTONIN;

EID: 33745268843     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresrev.2005.11.001     Document Type: Review

References (380)

1. Adams M.M., Shah R.A., Janssen W.G., and Morrison J.H. Different modes of hippocampal plasticity in response to estrogen in young and aged female rats. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 8071-8076
2. Adell A., Celada P., and Artigas F. The role of 5-HT1B receptors in the regulation of serotonin cell firing and release in the rat brain. J. Neurochem. 79 (2001) 172-182
3. Alves S.E., Weiland N.G., Hayashi S., and McEwen B.S. Immunocytochemical localization of nuclear estrogen receptors and progestin receptors within the rat dorsal raphe nucleus. J. Comp. Neurol. 391 (1998) 322-334
4. Alves S.E., Hoskin E., Lee S.J., Brake W.G., Ferguson D., Luine V., Allen P.B., Greengard P., and McEwen B.S. Serotonin mediates CA1 spine density but is not crucial for ovarian steroid regulation of synaptic plasticity in the adult rat dorsal hippocampus. Synapse 45 (2002) 143-151
5. Amateau S.K., Alt J.J., Stamps C.L., and McCarthy M.M. Brain estradiol content in newborn rats: sex differences, regional heterogeneity, and possible de novo synthesis by the female telencephalon. Endocrinology 145 (2004) 2906-2917
6. Andreen L., Sundstrom-Poromaa I., Bixo M., Andersson A., Nyberg S., and Backstrom T. Relationship between allopregnanolone and negative mood in postmenopausal women taking sequential hormone replacement therapy with vaginal progesterone. Psychoneuroendocrinology 30 (2005) 212-224
7. Artigas F., Celada P., Laruelle M., and Adell A. How does pindolol improve antidepressant action?. Trends Pharmacol. Sci. 22 (2001) 224-228
8. Astur R.S., Taylor L.B., Mamelak A.N., Philpott L., and Sutherland R.J. Humans with hippocampus damage display severe spatial memory impairments in a virtual Morris water task. Behav. Brain Res. 132 (2002) 77-84
9. Attali G., Weizman A., Gil-Ad I., and Rehavi M. Opposite modulatory effects of ovarian hormones on rat brain dopamine and serotonin transporters. Brain Res. 756 (1997) 153-159
10. Backstrom T. Epileptic seizures in women related to plasma estrogen and progesterone during the menstrual cycle. Acta Neurol. Scand. 54 (1976) 321-347
11. Backstrom T., Andersson A., Andree L., Birzniece V., Bixo M., Bjorn I., Haage D., Isaksson M., Johansson I.M., Lindblad C., Lundgren P., Nyberg S., Odmark I.S., Stromberg J., Sundstrom-Poromaa I., Turkmen S., Wahlstrom G., Wang M., Wihlback A.C., Zhu D., and Zingmark E. Pathogenesis in menstrual cycle-linked CNS disorders. Ann. N. Y. Acad. Sci. 1007 (2003) 42-53
12. Backstrom T., Andreen L., Birzniece V., Bjorn I., Johansson I.M., Nordenstam-Haghjo M., Nyberg S., Sundstrom-Poromaa I., Wahlstrom G., Wang M., and Zhu D. The role of hormones and hormonal treatments in premenstrual syndrome. CNS Drugs 17 (2003) 325-342
13. Baker L., Meldrum K.K., Wang M., Sankula R., Vanam R., Raiesdana A., Tsai B., Hile K., Brown J.W., and Meldrum D.R. The role of estrogen in cardiovascular disease. J. Surg. Res. 115 (2003) 325-344
14. Ballesteros J., and Callado L.F. Effectiveness of pindolol plus serotonin uptake inhibitors in depression: a meta-analysis of early and late outcomes from randomised controlled trials. J. Affect. Disord. 79 (2004) 137-147
15. 2 inhalation. Eur. J. Pharmacol. 261 (1994) 317-320
16. Barbaccia M.L., Roscetti G., Trabucchi M., Purdy R.H., Mostallino M.C., Concas A., and Biggio G. The effects of inhibitors of GABAergic transmission and stress on brain and plasma allopregnanolone concentrations. Br. J. Pharmacol. 120 (1997) 1582-1588
17. Barker M.J., Greenwood K.M., Jackson M., and Crowe S.F. Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: a meta-analysis. Arch. Clin. Neuropsychol. 19 (2004) 437-454
18. Barnes Jr. E.M. Use-dependent regulation of GABAA receptors. Int. Rev. Neurobiol. 39 (1996) 53-76
19. Barnes N.M., and Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 38 (1999) 1083-1152
20. Bateson A.N. Basic pharmacologic mechanisms involved in benzodiazepine tolerance and withdrawal. Curr. Pharm. Des. 8 (2002) 5-21
21. Baulieu E.E., and Robel P. Neurosteroids: a new brain function?. J. Steroid Biochem. Mol. Biol. 37 (1990) 395-403
22. Beck S.G., Birnstiel S., Choi K.C., and Pouliot W.A. Fluoxetine selectively alters 5-hydroxytryptamine1A and gamma-aminobutyric acidB receptor-mediated hyperpolarization in area CA1, but not area CA3, hippocampal pyramidal cells. J. Pharmacol. Exp. Ther. 281 (1997) 115-122
23. Behl C. Estrogen can protect neurons: modes of action. J. Steroid Biochem. Mol. Biol. 83 (2002) 195-197
24. Belelli D., Lambert J.J., Peters J.A., Wafford K., and Whiting P.J. The interaction of the general anesthetic etomidate with the gamma-aminobutyric acid type A receptor is influenced by a single amino acid. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 11031-11036
25. Belelli D., Casula A., Ling A., and Lambert J.J. The influence of subunit composition on the interaction of neurosteroids with GABA (A) receptors. Neuropharmacology 43 (2002) 651-661
26. Bernardi F., Pieri M., Stomati M., Luisi S., Palumbo M., Pluchino N., Ceccarelli C., and Genazzani A.R. Effect of different hormonal replacement therapies on circulating allopregnanolone and dehydroepiandrosterone levels in postmenopausal women. Gynecol. Endocrinol. 17 (2003) 65-77
27. Bethea C.L. Colocalization of progestin receptors with serotonin in raphe neurons of macaque. Neuroendocrinology 57 (1993) 1-6
28. Bethea C.L., and Widmann A.A. Differential expression of progestin receptor isoforms in the hypothalamus, pituitary, and endometrium of rhesus macaques. Endocrinology 139 (1998) 677-687
29. Bethea C.L., Mirkes S.J., Shively C.A., and Adams M.R. Steroid regulation of tryptophan hydroxylase protein in the dorsal raphe of macaques. Biol. Psychiatry 47 (2000) 562-576
30. Bethea C.L., Lu N.Z., Gundlah C., and Streicher J.M. Diverse actions of ovarian steroids in the serotonin neural system. Front. Neuroendocrinol. 23 (2002) 41-100
31. Bethea C.L., Mirkes S.J., Su A., and Michelson D. Effects of oral estrogen, raloxifene and arzoxifene on gene expression in serotonin neurons of macaques. Psychoneuroendocrinology 27 (2002) 431-445
32. Bhagwagar Z., Wylezinska M., Taylor M., Jezzard P., Matthews P.M., and Cowen P.J. Increased brain GABA concentrations following acute administration of a selective serotonin reuptake inhibitor. Am. J. Psychiatry 161 (2004) 368-370
33. Bicikova M., Lapcik O., Hampl R., Starka L., Knuppen R., Haupt O., and Dibbelt L. A novel radioimmunoassay of allopregnanolone. Steroids 60 (1995) 210-213
34. Bicikova M., Dibbelt L., Hill M., Hampl R., and Starka L. Allopregnanolone in women with premenstrual syndrome. Horm. Metab. Res. 30 (1998) 227-230
35. Biegon A., Bercovitz H., and Samuel D. Serotonin receptor concentration during the estrous cycle of the rat. Brain Res. 187 (1980) 221-225
36. Biegon A., Reches A., Snyder L., and McEwen B.S. Serotonergic and noradrenergic receptors in the rat brain: modulation by chronic exposure to ovarian hormones. Life Sci. 32 (1983) 2015-2021
37. Birzniece V., Johansson I.M., Wang M.D., Seckl J.R., Backstrom T., and Olsson T. Serotonin 5-HT (1A) receptor mRNA expression in dorsal hippocampus and raphe nuclei after gonadal hormone manipulation in female rats. Neuroendocrinology 74 (2001) 135-142
38. Birzniece V., Johansson I.M., Wang M.D., Backstrom T., and Olsson T. Ovarian hormone effects on 5-hydroxytryptamine (2A) and 5-hydroxytryptamine (2C) receptor mRNA expression in the ventral hippocampus and frontal cortex of female rats. Neurosci. Lett. 319 (2002) 157-161
39. Bitran D., Dugan M., Renda P., Ellis R., and Foley M. Anxiolytic effects of the neuroactive steroid pregnanolone (3 alpha-OH-5 beta-pregnan-20-one) after microinjection in the dorsal hippocampus and lateral septum. Brain Res. 850 (1999) 217-224
40. Bitran D., Foley M., Audette D., Leslie N., and Frye C.A. Activation of peripheral mitochondrial benzodiazepine receptors in the hippocampus stimulates allopregnanolone synthesis and produces anxiolytic-like effects in the rat. Psychopharmacology (Berlin) 151 (2000) 64-71
41. Bixo M., Backstrom T., Winblad B., Selstam G., and Andersson A. Comparison between pre- and postovulatory distributions of oestradiol and progesterone in the brain of the PMSG-treated rat. Acta Physiol. Scand. 128 (1986) 241-246
42. Bixo M., Backstrom T., Winblad B., and Andersson A. Estradiol and testosterone in specific regions of the human female brain in different endocrine states. J. Steroid Biochem. Mol. Biol. 55 (1995) 297-303
43. Bixo M., Andersson A., Winblad B., Purdy R.H., and Backstrom T. Progesterone, 5alpha-pregnane-3,20-dione and 3alpha-hydroxy-5alpha-pregnane-20-one in specific regions of the human female brain in different endocrine states. Brain Res. 764 (1997) 173-178
44. Bjorn I., Bixo M., Nojd K.S., Nyberg S., and Backstrom T. Negative mood changes during hormone replacement therapy: a comparison between two progestogens. Am. J. Obstet. Gynecol. 183 (2000) 1419-1426
45. Bjorn I., Sundstrom-Poromaa I., Bixo M., Nyberg S., Backstrom G., and Backstrom T. Increase of estrogen dose deteriorates mood during progestin phase in sequential hormonal therapy. J. Clin. Endocrinol. Metab. 88 (2003) 2026-2030
46. Blier P., Bergeron R., and de Montigny C. Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response. Neuropsychopharmacology 16 (1997) 333-338
47. Brambilla P., Perez J., Barale F., Schettini G., and Soares J.C. GABAergic dysfunction in mood disorders. Mol. Psychiatry 8 (2003) 721-737 (715)
48. Brandon N., Jovanovic J., and Moss S. Multiple roles of protein kinases in the modulation of gamma-aminobutyric acid (A) receptor function and cell surface expression. Pharmacol. Ther. 94 (2002) 113-122
49. Brandon N.J., Jovanovic J.N., Colledge M., Kittler J.T., Brandon J.M., Scott J.D., and Moss S.J. A-kinase anchoring protein 79/150 facilitates the phosphorylation of GABA (A) receptors by cAMP-dependent protein kinase via selective interaction with receptor beta subunits. Mol. Cell. Neurosci. 22 (2003) 87-97
50. Brett M., and Baxendale S. Motherhood and memory: a review. Psychoneuroendocrinology 26 (2001) 339-362
51. Brot M.D., Akwa Y., Purdy R.H., Koob G.F., and Britton K.T. The anxiolytic-like effects of the neurosteroid allopregnanolone: interactions with GABA (A) receptors. Eur. J. Pharmacol. 325 (1997) 1-7
52. Buhot M.C., Martin S., and Segu L. Role of serotonin in memory impairment. Ann. Med. 32 (2000) 210-221
53. Buhot M.C., Wolff M., Benhassine N., Costet P., Hen R., and Segu L. Spatial learning in the 5-HT1B receptor knockout mouse: selective facilitation/impairment depending on the cognitive demand. Learn. Mem. 10 (2003) 466-477
54. Buhot M.C., Wolff M., Savova M., Malleret G., Hen R., and Segu L. Protective effect of 5-HT1B receptor gene deletion on the age-related decline in spatial learning abilities in mice. Behav. Brain Res. 142 (2003) 135-142
55. Burns M.J., Cain V.A., and Husaini B.A. Depression, service utilization, and treatment costs among Medicare elderly: gender differences. Home Health Care Serv. Q. 19 (2001) 35-44
56. Cain D.P. Prior non-spatial pretraining eliminates sensorimotor disturbances and impairments in water maze learning caused by diazepam. Psychopharmacology (Berlin) 130 (1997) 313-319
57. Cain D.P., Saucier D., Hall J., Hargreaves E.L., and Boon F. Detailed behavioral analysis of water maze acquisition under APV or CNQX: contribution of sensorimotor disturbances to drug-induced acquisition deficits. Behav. Neurosci. 110 (1996) 86-102
58. Camacho-Arroyo I., Guerra-Araiza C., and Cerbon M.A. Progesterone receptor isoforms are differentially regulated by sex steroids in the rat forebrain. NeuroReport 9 (1998) 3993-3996
59. Carl P., Hogskilde S., Nielsen J.W., Sorensen M.B., Lindholm M., Karlen B., and Backstrom T. Pregnanolone emulsion. A preliminary pharmacokinetic and pharmacodynamic study of a new intravenous anaesthetic agent. Anaesthesia 45 (1990) 189-197
60. Carlson B.X., Engblom A.C., Kristiansen U., Schousboe A., and Olsen R.W. A single glycine residue at the entrance to the first membrane-spanning domain of the gamma-aminobutyric acid type A receptor beta (2) subunit affects allosteric sensitivity to GABA and anesthetics. Mol. Pharmacol. 57 (2000) 474-484
61. Cerillo G., Rees A., Manchanda N., Reilly C., Brogan I., White A., and Needham M. The oestrogen receptor regulates NFkappaB and AP-1 activity in a cell-specific manner. J. Steroid Biochem. Mol. Biol. 67 (1998) 79-88
62. Chan A.F., Mortola J.F., Wood S.H., and Yen S.S. Persistence of premenstrual syndrome during low-dose administration of the progesterone antagonist RU 486. Obstet. Gynecol. 84 (1994) 1001-1005
63. Chaput Y., de Montigny C., and Blier P. Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain. Naunyn-Schmiedebergs. Arch. Pharmacol. 333 (1986) 342-348
64. + currents in rat serotonergic neurones. J. Physiol. (London) 496 (1996) 129-137
65. Cho Y.H., Giese K.P., Tanila H., Silva A.J., and Eichenbaum H. Abnormal hippocampal spatial representations in alphaCaMKIIT286A and CREBalphaDelta-mice. Science 279 (1998) 867-869
66. Clarke W.P., and Maayani S. Estrogen effects on 5-HT1A receptors in hippocampal membranes from ovariectomized rats: functional and binding studies. Brain Res. 518 (1990) 287-291
67. Cohen N.J., and Squire L.R. Preserved learning and retention of pattern-analyzing skill in amnesia: dissociation of knowing how and knowing that. Science 210 (1980) 207-210
68. Cohen L.S., Miner C., Brown E.W., Freeman E., Halbreich U., Sundell K., and McCray S. Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries. Obstet. Gynecol. 100 (2002) 435-444
69. Collinson N., Kuenzi F.M., Jarolimek W., Maubach K.A., Cothliff R., Sur C., Smith A., Otu F.M., Howell O., Atack J.R., McKernan R.M., Seabrook G.R., Dawson G.R., Whiting P.J., and Rosahl T.W. Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the alpha 5 subunit of the GABAA receptor. J. Neurosci. 22 (2002) 5572-5580
70. Compagnone N.A., and Mellon S.H. Neurosteroids: biosynthesis and function of these novel neuromodulators. Front. Neuroendocrinol. 21 (2000) 1-56
71. Concas A., Follesa P., Barbaccia M.L., Purdy R.H., and Biggio G. Physiological modulation of GABA (A) receptor plasticity by progesterone metabolites. Eur. J. Pharmacol. 375 (1999) 225-235
72. Connolly C.N., Kittler J.T., Thomas P., Uren J.M., Brandon N.J., Smart T.G., and Moss S.J. Cell surface stability of gamma-aminobutyric acid type A receptors. Dependence on protein kinase C activity and subunit composition. J. Biol. Chem. 274 (1999) 36565-36572
73. Cornea-Hebert V., Riad M., Wu C., Singh S.K., and Descarries L. Cellular and subcellular distribution of the serotonin 5-HT2A receptor in the central nervous system of adult rat. J. Comp. Neurol. 409 (1999) 187-209
74. Corpechot C., Young J., Calvel M., Wehrey C., Veltz J.N., Touyer G., Mouren M., Prasad V.V., Banner C., and Sjovall J. Neurosteroids: 3 alpha-hydroxy-5 alpha-pregnan-20-one and its precursors in the brain, plasma, and steroidogenic glands of male and female rats. Endocrinology 133 (1993) 1003-1009
75. Corpéchot C., Collins B.E., Carey M.P., Tsouros A., Robel P., and Fry J.P. Brain neurosteroids during the mouse oestrous cycle. Brain. Res. 766 (1997) 276-280
76. Costa A.M., Spence K.T., Smith S.S., and ffrench-Mullen J.M. Withdrawal from the endogenous steroid progesterone results in GABAA currents insensitive to benzodiazepine modulation in rat CA1 hippocampus. J. Neurophysiol. 74 (1995) 464-469
77. Coyle J.E., and Nikolov D.B. GABARAP: lessons for synaptogenesis. Neuroscientist 9 (2003) 205-216
78. Crestani F., Lorez M., Baer K., Essrich C., Benke D., Laurent J.P., Belzung C., Fritschy J.M., Luscher B., and Mohler H. Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues. Nat. Neurosci. 2 (1999) 833-839
79. Crestani F., Keist R., Fritschy J.M., Benke D., Vogt K., Prut L., Bluthmann H., Mohler H., and Rudolph U. Trace fear conditioning involves hippocampal alpha5 GABA (A) receptors. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 8980-8985
80. Cyr M., Bosse R., and Di Paolo T. Gonadal hormones modulate 5-hydroxytryptamine2A receptors: emphasis on the rat frontal cortex. Neuroscience 83 (1998) 829-836
81. Czlonkowska A.I., Krzascik P., Sienkiewicz-Jarosz H., Siemiatkowski M., Szyndler J., Maciejak P., Bidzinski A., and Plaznik A. Tolerance to the anticonvulsant activity of midazolam and allopregnanolone in a model of picrotoxin seizures. Eur. J. Pharmacol. 425 (2001) 121-127
82. Damianisch K., Rupprecht R., and Lancel M. The influence of subchronic administration of the neurosteroid allopregnanolone on sleep in the rat. Neuropsychopharmacology 25 (2001) 576-584
83. de Groote L., Klompmakers A.A., Olivier B., and Westenberg H.G. Role of extracellular serotonin levels in the effect of 5-HT1B receptor blockade. Psychopharmacology (Berlin) 167 (2003) 153-158
84. DeMarzo A.M., Beck C.A., Onate S.A., and Edwards D.P. Dimerization of mammalian progesterone receptors occurs in the absence of DNA and is related to the release of the 90-kDa heat shock protein. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 72-76
85. de Quervain D.J., Roozendaal B., and McGaugh J.L. Stress and glucocorticoids impair retrieval of long-term spatial memory. Nature 394 (1998) 787-790
86. Devan B.D., Goad E.H., and Petri H.L. Dissociation of hippocampal and striatal contributions to spatial navigation in the water maze. Neurobiol. Learn. Mem. 66 (1996) 305-323
87. D'Hooge R., and De Deyn P.P. Applications of the Morris water maze in the study of learning and memory. Brain Res. Brain Res. Rev 36 (2001) 60-90
88. Di Carlo V. Serotoninergic fibers in dorsal roots of the spinal cord. Neurosci. Lett. 43 (1983) 119-125
89. Diez-Ariza M., Ramirez M.J., Lasheras B., and Del Rio J. Differential interaction between 5-HT3 receptors and GABAergic neurons inhibiting acetylcholine release in rat entorhinal cortex slices. Brain Res. 801 (1998) 228-232
90. Dimmock P.W., Wyatt K.M., Jones P.W., and O'Brien P.M. Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review. Lancet 356 (2000) 1131-1136
91. Di Paolo T., Levesque D., and Daigle M. A physiological dose of progesterone affects rat striatum biogenic amine metabolism. Eur. J. Pharmacol. 125 (1986) 11-16
92. Droogleever Fortuyn H.A., van Broekhoven F., Span P.N., Backstrom T., Zitman F.G., and Verkes R.J. Effects of PhD examination stress on allopregnanolone and cortisol plasma levels and peripheral benzodiazepine receptor density. Psychoneuroendocrinology 29 (2004) 1341-1344
93. Dubrovsky B., Tatarinov-Levin A., and Harris J. Effects of the active neurosteroid allotetrahydrodeoxycorticosterone on long-term potentiation in the rat hippocampus: implications for depression. Prog. Neuro-psychopharmacol. Biol. Psychiatry 28 (2004) 1029-1034
94. Elena Castro M., Diaz A., del Olmo E., and Pazos A. Chronic fluoxetine induces opposite changes in G protein coupling at pre and postsynaptic 5-HT1A receptors in rat brain. Neuropharmacology 44 (2003) 93-101
95. Essrich C., Lorez M., Benson J.A., Fritschy J.M., and Luscher B. Postsynaptic clustering of major GABAA receptor subtypes requires the gamma 2 subunit and gephyrin. Nat. Neurosci. 1 (1998) 563-571
96. Fabre-Nys C., Blache D., Hinton M.R., Goode J.A., and Kendrick K.M. Microdialysis measurement of neurochemical changes in the mediobasal hypothalamus of ovariectomized ewes during oestrus. Brain Res. 649 (1994) 282-296
97. Farr S.A., Flood J.F., and Morley J.E. The effect of cholinergic, GABAergic, serotonergic, and glutamatergic receptor modulation on posttrial memory processing in the hippocampus. Neurobiol. Learn. Mem. 73 (2000) 150-167
98. Favale E., Rubino V., Mainardi P., Lunardi G., and Albano C. Anticonvulsant effect of fluoxetine in humans. Neurology 45 (1995) 1926-1927
99. Follesa P., Floris S., Tuligi G., Mostallino M.C., Concas A., and Biggio G. Molecular and functional adaptation of the GABA (A) receptor complex during pregnancy and after delivery in the rat brain. Eur. J. Neurosci. 10 (1998) 2905-2912
100. Follesa P., Serra M., Cagetti E., Pisu M.G., Porta S., Floris S., Massa F., Sanna E., and Biggio G. Allopregnanolone synthesis in cerebellar granule cells: roles in regulation of GABA (A) receptor expression and function during progesterone treatment and withdrawal. Mol. Pharmacol. 57 (2000) 1262-1270
101. Frankfurt M., McKittrick C.R., Mendelson S.D., and McEwen B.S. Effect of 5,7-dihydroxytryptamine, ovariectomy and gonadal steroids on serotonin receptor binding in rat brain. Neuroendocrinology 59 (1994) 245-250
102. Freeman E.W. Premenstrual syndrome and premenstrual dysphoric disorder: definitions and diagnosis. Psychoneuroendocrinology 28 Suppl. 3 (2003) 25-37
103. Freund T.F., Gulyas A.I., Acsady L., Gorcs T., and Toth K. Serotonergic control of the hippocampus via local inhibitory interneurons. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 8501-8505
104. Friedman L., Gibbs T.T., and Farb D.H. Gamma-aminobutyric acidA receptor regulation: chronic treatment with pregnanolone uncouples allosteric interactions between steroid and benzodiazepine recognition sites. Mol. Pharmacol. 44 (1993) 191-197
105. Frye C.A., and Sturgis J.D. Neurosteroids affect spatial/reference, working, and long-term memory of female rats. Neurobiol. Learn. Mem. 64 (1995) 83-96
106. Gallo M.A., and Smith S.S. Progesterone withdrawal decreases latency to and increases duration of electrified prod burial: a possible rat model of PMS anxiety. Pharmacol. Biochem. Behav. 46 (1993) 897-904
107. Garraway S.M., and Hochman S. Pharmacological characterization of serotonin receptor subtypes modulating primary afferent input to deep dorsal horn neurons in the neonatal rat. Br. J. Pharmacol. 132 (2001) 1789-1798
108. Gazzaley A.H., Weiland N.G., McEwen B.S., and Morrison J.H. Differential regulation of NMDAR1 mRNA and protein by estradiol in the rat hippocampus. J. Neurosci. 16 (1996) 6830-6838
109. - ionophore by steroids in rat brain. Eur. J. Pharmacol. 136 (1987) 419-423
110. Gellman R.L., and Aghajanian G.K. Pyramidal cells in piriform cortex receive a convergence of inputs from monoamine activated GABAergic interneurons. Brain Res. 600 (1993) 63-73
111. Gellman R.L., and Aghajanian G.K. Serotonin2 receptor-mediated excitation of interneurons in piriform cortex: antagonism by atypical antipsychotic drugs. Neuroscience 58 (1994) 515-525
112. Genazzani A.R., Petraglia F., Bernardi F., Casarosa E., Salvestroni C., Tonetti A., Nappi R.E., Luisi S., Palumbo M., Purdy R.H., and Luisi M. Circulating levels of allopregnanolone in humans: gender, age, and endocrine influences. J. Clin. Endocrinol. Metab. 83 (1998) 2099-2103
113. Ghoneim M.M., Hinrichs J.V., and Mewaldt S.P. Dose-response analysis of the behavioral effects of diazepam: I. Learning and memory. Psychopharmacology (Berlin) 82 (1984) 291-295
114. Girdler S.S., Straneva P.A., Light K.C., Pedersen C.A., and Morrow A.L. Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder. Biol. Psychiatry 49 (2001) 788-797
115. Goodnick P.J., and Goldstein B.J. Selective serotonin reuptake inhibitors in affective disorders: I. Basic pharmacology. J. Psychopharmacol. 12 (1998) S5-S20
116. Goodnick P.J., Chaudry T., Artadi J., and Arcey S. Women's issues in mood disorders. Expert Opin. Pharmacother. 1 (2000) 903-916
117. Gould E., Woolley C.S., Frankfurt M., and McEwen B.S. Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood. J. Neurosci. 10 (1990) 1286-1291
118. Greco B., Allegretto E.A., Tetel M.J., and Blaustein J.D. Coexpression of ER beta with ER alpha and progestin receptor proteins in the female rat forebrain: effects of estradiol treatment. Endocrinology 142 (2001) 5172-5181
119. Griffin L.D., and Mellon S.H. Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 13512-13517
120. Grobin A.C., and Morrow A.L. 3Alpha-hydroxy-5alpha-pregnan-20-one exposure reduces GABA (A) receptor alpha4 subunit mRNA levels. Eur. J. Pharmacol. 409 (2000) R1-R2
121. Guennoun R., Fiddes R.J., Gouezou M., Lombes M., and Baulieu E.E. A key enzyme in the biosynthesis of neurosteroids, 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase (3 beta-HSD) is expressed in rat brain. Brain Res. Mol Brain Res. 30 (1995) 287-300
122. Guerra-Araiza C., Reyna-Neyra A., Salazar A.M., Cerbon M.A., Morimoto S., and Camacho-Arroyo I. Progesterone receptor isoforms expression in the prepuberal and adult male rat brain. Brain Res. Bull. 54 (2001) 13-17
123. Guerra-Araiza C., Villamar-Cruz O., Gonzalez-Arenas A., Chavira R., and Camacho-Arroyo I. Changes in progesterone receptor isoforms content in the rat brain during the oestrous cycle and after oestradiol and progesterone treatments. J. Neuroendocrinol. 15 (2003) 984-990
124. Gulinello M., Gong Q.H., Li X., and Smith S.S. Short-term exposure to a neuroactive steroid increases alpha4 GABA (A) receptor subunit levels in association with increased anxiety in the female rat. Brain Res. 910 (2001) 55-66
125. Gulyas A.I., Acsady L., and Freund T.F. Structural basis of the cholinergic and serotonergic modulation of GABAergic neurons in the hippocampus. Neurochem. Int. 34 (1999) 359-372
126. Gundlah C., Simon L.D., and Auerbach S.B. Differences in hypothalamic serotonin between estrous phases and gender: an in vivo microdialysis study. Brain Res. 785 (1998) 91-96
127. Gundlah C., Pecins-Thompson M., Schutzer W.E., and Bethea C.L. Ovarian steroid effects on serotonin 1A, 2A and 2C receptor mRNA in macaque hypothalamus. Brain Res. Mol Brain Res. 63 (1999) 325-339
128. Gundlah C., Kohama S.G., Mirkes S.J., Garyfallou V.T., Urbanski H.F., and Bethea C.L. Distribution of estrogen receptor beta (ERbeta) mRNA in hypothalamus, midbrain and temporal lobe of spayed macaque: continued expression with hormone replacement. Brain Res. Mol Brain Res. 76 (2000) 191-204
129. Gundlah C., Lu N.Z., Mirkes S.J., and Bethea C.L. Estrogen receptor beta (ERbeta) mRNA and protein in serotonin neurons of macaques. Brain Res. Mol Brain Res. 91 (2001) 14-22
130. Halbreich U. The etiology, biology, and evolving pathology of premenstrual syndromes. Psychoneuroendocrinology 28 Suppl. 3 (2003) 55-99
131. Hammarback S., Backstrom T., Holst J., von Schoultz B., and Lyrenas S. Cyclical mood changes as in the premenstrual tension syndrome during sequential estrogen-progestagen postmenopausal replacement therapy. Acta Obstet. Gynecol. Scand. 64 (1985) 393-397
132. Hammarback S., Ekholm U.B., and Backstrom T. Spontaneous anovulation causing disappearance of cyclical symptoms in women with the premenstrual syndrome. Acta Endocrinol. (Copenh) 125 (1991) 132-137
133. Harney S.C., Frenguelli B.G., and Lambert J.J. Phosphorylation influences neurosteroid modulation of synaptic GABAA receptors in rat CA1 and dentate gyrus neurones. Neuropharmacology 45 (2003) 873-883
134. Harris K.M., and Kater S.B. Dendritic spines: cellular specializations imparting both stability and flexibility to synaptic function. Annu. Rev. Neurosci. 17 (1994) 341-371
135. Hart S.M. Modulation of nuclear receptor dependent transcription. Biol. Res. 35 (2002) 295-303
136. Hays J., Ockene J.K., Brunner R.L., Kotchen J.M., Manson J.E., Patterson R.E., Aragaki A.K., Shumaker S.A., Brzyski R.G., LaCroix A.Z., Granek I.A., and Valanis B.G. Effects of estrogen plus progestin on health-related quality of life. N. Engl. J. Med. 348 (2003) 1839-1854
137. Heisler L.K., and Tecott L.H. Knockout Corner: Neurobehavioural consequences of a serotonin 5-HT (2C) receptor gene mutation. Int. J. Neuropsychopharmacol. 2 (1999) 67-69
138. Hensler J.G. Regulation of 5-HT1A receptor function in brain following agonist or antidepressant administration. Life Sci. 72 (2003) 1665-1682
139. Hindmarch I. Beyond the monoamine hypothesis: mechanisms, molecules and methods. Eur. Psychiatr. 17 Suppl. 3 (2002) 294-299
140. Hjorth S., and Tao R. The putative 5-HT1B receptor agonist CP-93,129 suppresses rat hippocampal 5-HT release in vivo: comparison with RU 24969. Eur. J. Pharmacol. 209 (1991) 249-252
141. Hojo Y., Hattori T.A., Enami T., Furukawa A., Suzuki K., Ishii H.T., Mukai H., Morrison J.H., Janssen W.G., Kominami S., Harada N., Kimoto T., and Kawato S. Adult male rat hippocampus synthesizes estradiol from pregnenolone by cytochromes P45017alpha and P450 aromatase localized in neurons. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 865-870
142. Holbrook A.M., Crowther R., Lotter A., Cheng C., and King D. Meta-analysis of benzodiazepine use in the treatment of insomnia. CMAJ 162 (2000) 225-233
143. Holdstock L., Penland S.N., Morrow A.L., and de Wit H. Moderate doses of ethanol fail to increase plasma levels of neurosteroid 3alpha-hydroxy-5alpha-pregnan-20-one-like immunoreactivity in healthy men and women. Psychopharmacology (Berlin) (2005) 1-9
144. Hu Z.Y., Jung-Testas I., Robel P., and Baulieu E.E. Neurosteroids: steroidogenesis in primary cultures of rat glial cells after release of aminoglutethimide blockade. Biochem. Biophys. Res. Commun. 161 (1989) 917-922
145. Impagnatiello F., Pesold C., Longone P., Caruncho H., Fritschy J.M., Costa E., and Guidotti A. Modifications of gamma-aminobutyric acidA receptor subunit expression in rat neocortex during tolerance to diazepam. Mol. Pharmacol. 49 (1996) 822-831
146. Jakab R.L., and Goldman-Rakic P.S. Segregation of serotonin 5-HT2A and 5-HT3 receptors in inhibitory circuits of the primate cerebral cortex. J. Comp. Neurol. 417 (2000) 337-348
147. Jensen E.V., and DeSombre E.R. Mechanism of action of the female sex hormones. Annu. Rev. Biochem. 41 (1972) 203-230
148. Johansson I.M., Birzniece V., Lindblad C., Olsson T., and Backstrom T. Allopregnanolone inhibits learning in the Morris water maze. Brain Res. 934 (2002) 125-131
149. Jung-Testas I., Renoir M., Bugnard H., Greene G.L., and Baulieu E.E. Demonstration of steroid hormone receptors and steroid action in primary cultures of rat glial cells. J. Steroid. Biochem. Mol. Biol. 41 (1992) 621-631
150. Jung-Testas I., Weintraub H., Dupuis D., Eychenne B., Baulieu E.E., and Robel P. Low density lipoprotein-receptors in primary cultures of rat glial cells. J. Steroid Biochem. Mol. Biol. 42 (1992) 597-605
151. Jurevics H., and Morell P. Cholesterol for synthesis of myelin is made locally, not imported into brain. J. Neurochem. 64 (1995) 895-901
152. Kalkhoven E., Wissink S., van der Saag P.T., and van der Burg B. Negative interaction between the RelA (p65) subunit of NF-kappaB and the progesterone receptor. J. Biol. Chem. 271 (1996) 6217-6224
153. Kang I., and Miller L.G. Decreased GABAA receptor subunit mRNA concentrations following chronic lorazepam administration. Br. J. Pharmacol. 103 (1991) 1285-1287
154. Kapur J., and Macdonald R.L. Cyclic AMP-dependent protein kinase enhances hippocampal dentate granule cell GABAA receptor currents. J. Neurophysiol. 76 (1996) 2626-2634
155. Kato J., Hirata S., Nozawa A., and Yamada-Mouri N. Gene expression of progesterone receptor isoforms in the rat brain. Horm. Behav. 28 (1994) 454-463
156. Kelly M.J., Moss R.L., and Dudley C.A. The effects of microelectrophoretically applied estrogen, cortisol and acetylcholine on medial preoptic-septal unit activity throughout the estrous cycle of the female rat. Exp. Brain Res. 30 (1977) 53-64
157. Khisti R.T., and Chopde C.T. Serotonergic agents modulate antidepressant-like effect of the neurosteroid 3alpha-hydroxy-5alpha-pregnan-20-one in mice. Brain Res. 865 (2000) 291-300
158. Khisti R.T., VanDoren M.J., O'Buckley T., and Morrow A.L. Neuroactive steroid 3 alpha-hydroxy-5 alpha-pregnan-20-one modulates ethanol-induced loss of righting reflex in rats. Brain Res. 980 (2003) 255-265
159. Kia H.K., Miquel M.C., Brisorgueil M.J., Daval G., Riad M., El Mestikawy S., Hamon M., and Verge D. Immunocytochemical localization of serotonin1A receptors in the rat central nervous system. J. Comp. Neurol. 365 (1996) 289-305
160. Kittler J.T., and Moss S.J. Modulation of GABAA receptor activity by phosphorylation and receptor trafficking: implications for the efficacy of synaptic inhibition. Curr. Opin. Neurobiol. 13 (2003) 341-347
161. Kittler J.T., Delmas P., Jovanovic J.N., Brown D.A., Smart T.G., and Moss S.J. Constitutive endocytosis of GABAA receptors by an association with the adaptin AP2 complex modulates inhibitory synaptic currents in hippocampal neurons. J. Neurosci. 20 (2000) 7972-7977
162. Kittler J.T., Wang J., Connolly C.N., Vicini S., Smart T.G., and Moss S.J. Analysis of GABAA receptor assembly in mammalian cell lines and hippocampal neurons using gamma 2 subunit green fluorescent protein chimeras. Mol. Cell. Neurosci. 16 (2000) 440-452
163. Kleinrok Z. Biosynthesis and metabolism of 5-hydroxytryptamine in the central nervous system. Pol. J. Pharmacol. Pharm. 27 (1975) 3-12
164. Kneussel M., and Betz H. Clustering of inhibitory neurotransmitter receptors at developing postsynaptic sites: the membrane activation model. Trends. Neurosci. 23 (2000) 429-435
165. Kneussel M., Brandstatter J.H., Laube B., Stahl S., Muller U., and Betz H. Loss of postsynaptic GABA (A) receptor clustering in gephyrin-deficient mice. J. Neurosci. 19 (1999) 9289-9297
166. Kohchi C., Ukena K., and Tsutsui K. Age- and region-specific expressions of the messenger RNAs encoding for steroidogenic enzymes p450scc, P450c17 and 3beta-HSD in the postnatal rat brain. Brain Res. 801 (1998) 233-238
167. Kokate T.G., Yamaguchi S., Pannell L.K., Rajamani U., Carroll D.M., Grossman A.B., and Rogawski M.A. Lack of anticonvulsant tolerance to the neuroactive steroid pregnanolone in mice. J. Pharmacol. Exp. Ther. 287 (1998) 553-558
168. Kokate T.G., Juhng K.N., Kirkby R.D., Llamas J., Yamaguchi S., and Rogawski M.A. Convulsant actions of the neurosteroid pregnenolone sulfate in mice. Brain Res. 831 (1999) 119-124
169. Koksma J.J., van Kesteren R.E., Rosahl T.W., Zwart R., Smit A.B., Luddens H., and Brussaard A.B. Oxytocin regulates neurosteroid modulation of GABA (A) receptors in supraoptic nucleus around parturition. J. Neurosci. 23 (2003) 788-797
170. Koldzic-Zivanovic N., Seitz P.K., Watson C.S., Cunningham K.A., and Thomas M.L. Intracellular signaling involved in estrogen regulation of serotonin reuptake. Mol. Cell. Endocrinol. 226 (2004) 33-42
171. Korpi E.R., Grunder G., and Luddens H. Drug interactions at GABA (A) receptors. Prog. Neurobiol. 67 (2002) 113-159
172. Korpi E.R., Mihalek R.M., Sinkkonen S.T., Hauer B., Hevers W., Homanics G.E., Sieghart W., and Luddens H. Altered receptor subtypes in the forebrain of GABA (A) receptor delta subunit-deficient mice: recruitment of gamma 2 subunits. Neuroscience 109 (2002) 733-743
173. Krajnak K., Rosewell K.L., Duncan M.J., and Wise P.M. Aging, estradiol and time of day differentially affect serotonin transporter binding in the central nervous system of female rats. Brain Res. 990 (2003) 87-94
174. Kressler D., Schreiber S.N., Knutti D., and Kralli A. The PGC-1-related protein PERC is a selective coactivator of estrogen receptor alpha. J. Biol. Chem. 277 (2002) 13918-13925
175. Kugaya A., Epperson C.N., Zoghbi S., van Dyck C.H., Hou Y., Fujita M., Staley J.K., Garg P.K., Seibyl J.P., and Innis R.B. Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in postmenopausal women. Am. J. Psychiatry 160 (2003) 1522-1524
176. Kuiper G.G., and Gustafsson J.A. The novel estrogen receptor-beta subtype: potential role in the cell- and promoter-specific actions of estrogens and anti-estrogens. FEBS Lett. 410 (1997) 87-90
177. Kuiper G.G., Enmark E., Pelto-Huikko M., Nilsson S., and Gustafsson J.A. Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 5925-5930
178. Kuiper G.G., Carlsson B., Grandien K., Enmark E., Haggblad J., Nilsson S., and Gustafsson J.A. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138 (1997) 863-870
179. Kumar S., Sieghart W., and Morrow A.L. Association of protein kinase C with GABA (A) receptors containing alpha1 and alpha4 subunits in the cerebral cortex: selective effects of chronic ethanol consumption. J. Neurochem. 82 (2002) 110-117
180. Lader M.H., and Petursson H. Benzodiazepine derivatives-Side effects and dangers. Biol. Psychiatry 16 (1981) 1195-1201
181. Ladurelle N., Eychenne B., Denton D., Blair-West J., Schumacher M., Robel P., and Baulieu E. Prolonged intracerebroventricular infusion of neurosteroids affects cognitive performances in the mouse. Brain Res. 858 (2000) 371-379
182. Lambert J.J., Belelli D., Harney S.C., Peters J.A., and Frenguelli B.G. Modulation of native and recombinant GABA (A) receptors by endogenous and synthetic neuroactive steroids. Brain Res. Brain Res. Rev. 37 (2001) 68-80
183. Landgren S., Aasly J., Backstrom T., Dubrovsky B., and Danielsson E. The effect of progesterone and its metabolites on the interictal epileptiform discharge in the cat's cerebral cortex. Acta Physiol. Scand. 131 (1987) 33-42
184. Landgren S., Wang M.D., Backstrom T., and Johansson S. Interaction between 3 alpha-hydroxy-5 alpha-pregnan-20-one and carbachol in the control of neuronal excitability in hippocampal slices of female rats in defined phases of the oestrus. Acta Physiol. Scand. 162 (1998) 77-88
185. Landry M., and Di Paolo T. Effect of chronic estradiol, tamoxifen or raloxifene treatment on serotonin 5-HT1A receptor. Brain Res. Mol. Brain Res. 112 (2003) 82-89
186. Lee S.J., and McEwen B.S. Neurotrophic and neuroprotective actions of estrogens and their therapeutic implications. Annu. Rev. Pharmacol. Toxicol. 41 (2001) 569-591
187. Lee J.L., Everitt B.J., and Thomas K.L. Independent cellular processes for hippocampal memory consolidation and reconsolidation. Science 304 (2004) 839-843
188. Le Goascogne C., Robel P., Gouezou M., Sananes N., Baulieu E.E., and Waterman M. Neurosteroids: cytochrome P-450scc in rat brain. Science 237 (1987) 1212-1215
189. Li T.K., Lumeng L., McBride W.J., and Murphy J.M. Rodent lines selected for factors affecting alcohol consumption. Alcohol Alcohol., Suppl. 1 (1987) 91-96
190. Li M., Szabo A., and Rosenberg H.C. Down-regulation of benzodiazepine binding to alpha 5 subunit-containing gamma-aminobutyric Acid (A) receptors in tolerant rat brain indicates particular involvement of the hippocampal CA1 region. J. Pharmacol. Exp. Ther. 295 (2000) 689-696
191. Li C., Brake W.G., Romeo R.D., Dunlop J.C., Gordon M., Buzescu R., Magarinos A.M., Allen P.B., Greengard P., Luine V., and McEwen B.S. Estrogen alters hippocampal dendritic spine shape and enhances synaptic protein immunoreactivity and spatial memory in female mice. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 2185-2190
192. Lilly S.M., Zeng X.J., and Tietz E.I. Role of protein kinase A in GABAA receptor dysfunction in CA1 pyramidal cells following chronic benzodiazepine treatment. J. Neurochem. 85 (2003) 988-998
193. Lisman J., Schulman H., and Cline H. The molecular basis of CaMKII function in synaptic and behavioural memory. Nat. Rev., Neurosci. 3 (2002) 175-190
194. Liu X., Yao J., Pisha E., Yang Y., Hua Y., van Breemen R.B., and Bolton J.L. Oxidative DNA damage induced by equine estrogen metabolites: role of estrogen receptor alpha. Chem. Res. Toxicol. 15 (2002) 512-519
195. Liu L., Wong T.P., Pozza M.F., Lingenhoehl K., Wang Y., Sheng M., Auberson Y.P., and Wang Y.T. Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticity. Science 304 (2004) 1021-1024
196. Lombardi I., Luisi S., Quirici B., Monteleone P., Bernardi F., Liut M., Casarosa E., Palumbo M., Petraglia F., and Genazzani A.R. Adrenal response to adrenocorticotropic hormone stimulation in patients with premenstrual syndrome. Gynecol. Endocrinol. 18 (2004) 79-87
197. Longo L.P., and Johnson B. Addiction: Part I. Benzodiazepines-side effects, abuse risk and alternatives. Am. Fam. Phys. 61 (2000) 2121-2128
198. Longone P., Impagnatiello F., Guidotti A., and Costa E. Reversible modification of GABAA receptor subunit mRNA expression during tolerance to diazepam-induced cognition dysfunction. Neuropharmacology 35 (1996) 1465-1473
199. Low K., Crestani F., Keist R., Benke D., Brunig I., Benson J.A., Fritschy J.M., Rulicke T., Bluethmann H., Mohler H., and Rudolph U. Molecular and neuronal substrate for the selective attenuation of anxiety. Science 290 (2000) 131-134
200. Lu N.Z., Shlaes T.A., Gundlah C., Dziennis S.E., Lyle R.E., and Bethea C.L. Ovarian steroid action on tryptophan hydroxylase protein and serotonin compared to localization of ovarian steroid receptors in midbrain of guinea pigs. Endocrine 11 (1999) 257-267
201. Lu N.Z., and Bethea C.L. Ovarian steroid regulation of 5-HT1A receptor binding and G protein activation in female monkeys. Neuropsychopharmacology 27 (2002) 12-24
202. Lu N.Z., Eshleman A.J., Janowsky A., and Bethea C.L. Ovarian steroid regulation of serotonin reuptake transporter (SERT) binding, distribution, and function in female macaques. Mol. Psychiatry 8 (2003) 353-360
203. Luine V.N. Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp. Neurol. 89 (1985) 484-490
204. Luisi S., Petraglia F., Benedetto C., Nappi R.E., Bernardi F., Fadalti M., Reis F.M., Luisi M., and Genazzani A.R. Serum allopregnanolone levels in pregnant women: changes during pregnancy, at delivery, and in hypertensive patients. J. Clin. Endocrinol. Metab. 85 (2000) 2429-2433
205. Lundgren P., Stromberg J., Backstrom T., and Wang M. Allopregnanolone-stimulated GABA-mediated chloride ion flux is inhibited by 3beta-hydroxy-5alpha-pregnan-20-one (isoallopregnanolone). Brain Res. 982 (2003) 45-53
206. Lynch M.A. Long-term potentiation and memory. Physiol. Rev. 84 (2004) 87-136
207. Macdonald R.L. Ethanol, gamma-aminobutyrate type A receptors, and protein kinase C phosphorylation. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 3633-3635
208. Magos A.L., Brewster E., Singh R., O'Dowd T., Brincat M., and Studd J.W. The effects of norethisterone in postmenopausal women on oestrogen replacement therapy: a model for the premenstrual syndrome. Br. J. Obstet. Gynaecol. 93 (1986) 1290-1296
209. Maguire E.A., Frackowiak R.S., and Frith C.D. Recalling routes around london: activation of the right hippocampus in taxi drivers. J. Neurosci. 17 (1997) 7103-7110
210. Maguire E.A., Gadian D.G., Johnsrude I.S., Good C.D., Ashburner J., Frackowiak R.S., and Frith C.D. Navigation-related structural change in the hippocampi of taxi drivers. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 4398-4403
211. Maitra R., and Reynolds J.N. Modulation of GABA (A) receptor function by neuroactive steroids: evidence for heterogeneity of steroid sensitivity of recombinant GABA (A) receptor isoforms. Can. J. Physiol. Pharmacol. 76 (1998) 909-920
212. Majewska M.D., Harrison N.L., Schwartz R.D., Barker J.L., and Paul S.M. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 232 (1986) 1004-1007
213. Maki P.M., Zonderman A.B., and Resnick S.M. Enhanced verbal memory in nondemented elderly women receiving hormone-replacement therapy. Am. J. Psychiatry 158 (2001) 227-233
214. Maki P.M., Rich J.B., and Rosenbaum R.S. Implicit memory varies across the menstrual cycle: estrogen effects in young women. Neuropsychologia 40 (2002) 518-529
215. Man M.S., MacMillan I., Scott J., and Young A.H. Mood, neuropsychological function and cognitions in premenstrual dysphoric disorder. Psychol. Med. 29 (1999) 727-733
216. Marsh M., and McMahon H.T. The structural era of endocytosis. Science 285 (1999) 215-220
217. Marshall F.H., Stratton S.C., Mullings J., Ford E., Worton S.P., Oakley N.R., and Hagan R.M. Development of tolerance in mice to the sedative effects of the neuroactive steroid minaxolone following chronic exposure. Pharmacol. Biochem. Behav. 58 (1997) 1-8
218. Masand P.S., and Gupta S. Selective serotonin-reuptake inhibitors: an update. Harv. Rev. Psychiatr. 7 (1999) 69-84
219. Maswood S., Truitt W., Hotema M., Caldarola-Pastuszka M., and Uphouse L. Estrous cycle modulation of extracellular serotonin in mediobasal hypothalamus: role of the serotonin transporter and terminal autoreceptors. Brain Res. 831 (1999) 146-154
220. Matthews D.B., Morrow A.L., Tokunaga S., and McDaniel J.R. Acute ethanol administration and acute allopregnanolone administration impair spatial memory in the Morris water task. Alcohol., Clin. Exp. Res. 26 (2002) 1747-1751
221. Mattson M.P., Robinson N., and Guo Q. Estrogens stabilize mitochondrial function and protect neural cells against the pro-apoptotic action of mutant presenilin-1. NeuroReport 8 (1997) 3817-3821
222. Mayo W., Dellu F., Robel P., Cherkaoui J., Le Moal M., Baulieu E.E., and Simon H. Infusion of neurosteroids into the nucleus basalis magnocellularis affects cognitive processes in the rat. Brain Res. 607 (1993) 324-328
223. McCoy S.J., Beal J.M., and Watson G.H. Endocrine factors and postpartum depression, A selected review. J. Reprod. Med. 48 (2003) 402-408
224. McDonald B.J., Amato A., Connolly C.N., Benke D., Moss S.J., and Smart T.G. Adjacent phosphorylation sites on GABAA receptor beta subunits determine regulation by cAMP-dependent protein kinase. Nat. Neurosci. 1 (1998) 23-28
225. McEwen B.S. Invited review: estrogens effects on the brain: multiple sites and molecular mechanisms. J. Appl. Physiol. 91 (2001) 2785-2801
226. McQueen J.K., Wilson H., and Fink G. Estradiol-17 beta increases serotonin transporter (SERT) mRNA levels and the density of SERT-binding sites in female rat brain. Brain Res. Mol. Brain Res. 45 (1997) 13-23
227. Mehta A.K., and Ticku M.K. An update on GABAA receptors. Brain Res. Brain Res. Rev. 29 (1999) 196-217
228. Meiri N., Sun M.K., Segal Z., and Alkon D.L. Memory and long-term potentiation (LTP) dissociated: normal spatial memory despite CA1 LTP elimination with Kv1.4 antisense. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 15037-15042
229. Mendelson S.D., McKittrick C.R., and McEwen B.S. Autoradiographic analyses of the effects of estradiol benzoate on [3H]paroxetine binding in the cerebral cortex and dorsal hippocampus of gonadectomized male and female rats. Brain Res. 601 (1993) 299-302
230. Mengod G., Nguyen H., Le H., Waeber C., Lubbert H., and Palacios J.M. The distribution and cellular localization of the serotonin 1C receptor mRNA in the rodent brain examined by in situ hybridization histochemistry, Comparison with eceptor binding distribution. Neuroscience 35 (1990) 577-591
231. Meyerson B.J. Relationship between the anesthetic and gestagenic action and estrous behavior-inducing activity of different progestins. Endocrinology 81 (1967) 369-374
232. Mihalek R.M., Banerjee P.K., Korpi E.R., Quinlan J.J., Firestone L.L., Mi Z.P., Lagenaur C., Tretter V., Sieghart W., Anagnostaras S.G., Sage J.R., Fanselow M.S., Guidotti A., Spigelman I., Li Z., DeLorey T.M., Olsen R.W., and Homanics G.E. Attenuated sensitivity to neuroactive steroids in gamma-aminobutyrate type A receptor delta subunit knockout mice. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 12905-12910
233. Miller K.J., Conney J.C., Rasgon N.L., Fairbanks L.A., and Small G.W. Mood symptoms and cognitive performance in women estrogen users and nonusers and men. J. Am. Geriatr. Soc. 50 (2002) 1826-1830
234. Monteleone P., Luisi S., Tonetti A., Bernardi F., Genazzani A.D., Luisi M., Petraglia F., and Genazzani A.R. Allopregnanolone concentrations and premenstrual syndrome. Eur. J. Endocrinol. 142 (2000) 269-273
235. Moore R.Y., Halaris A.E., and Jones B.E. Serotonin neurons of the midbrain raphe: ascending projections. J. Comp. Neurol. 180 (1978) 417-438
236. Morales M., Battenberg E., de Lecea L., and Bloom F.E. The type 3 serotonin receptor is expressed in a subpopulation of GABAergic neurons in the rat neocortex and hippocampus. Brain Res. 731 (1996) 199-202
237. Morrell M.J. Epilepsy in women: the science of why it is special. Neurology 53 (1999) S42-S48
238. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods 11 (1984) 47-60
239. Morris R.G., Anderson E., Lynch G.S., and Baudry M. Selective impairment of learning and blockade of long-term potentiation by an N-methyl-d-aspartate receptor antagonist, AP5. Nature 319 (1986) 774-776
240. Morrow A.L., VanDoren M.J., Penland S.N., and Matthews D.B. The role of GABAergic neuroactive steroids in ethanol action, tolerance and dependence. Brain Res. Brain Res. Rev. 37 (2001) 98-109
241. Moses E.L., Drevets W.C., Smith G., Mathis C.A., Kalro B.N., Butters M.A., Leondires M.P., Greer P.J., Lopresti B., Loucks T.L., and Berga S.L. Effects of estradiol and progesterone administration on human serotonin 2A receptor binding: a PET study. Biol. Psychiatry 48 (2000) 854-860
242. Moses-Kolko E.L., Berga S.L., Greer P.J., Smith G., Cidis Meltzer C., and Drevets W.C. Widespread increases of cortical serotonin type 2A receptor availability after hormone therapy in euthymic postmenopausal women. Fertil. Steril. 80 (2003) 554-559
243. Murphy D.D., Cole N.B., Greenberger V., and Segal M. Estradiol increases dendritic spine density by reducing GABA neurotransmission in hippocampal neurons. J. Neurosci. 18 (1998) 2550-2559
244. Nakazawa K., Quirk M.C., Chitwood R.A., Watanabe M., Yeckel M.F., Sun L.D., Kato A., Carr C.A., Johnston D., Wilson M.A., and Tonegawa S. Requirement for hippocampal CA3 NMDA receptors in associative memory recall. Science 297 (2002) 211-218
245. Nishizawa S., Benkelfat C., Young S.N., Leyton M., Mzengeza S., de Montigny C., Blier P., and Diksic M. Differences between males and females in rates of serotonin synthesis in human brain. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 5308-5313
246. Norberg L., Wahlstrom G., and Backstrom T. The anaesthetic potency of 3 alpha-hydroxy-5 alpha-pregnan-20-one and 3 alpha-hydroxy-5 beta-pregnan-20-one determined with an intravenous EEG-threshold method in male rats. Pharmacol. Toxicol. 61 (1987) 42-47
247. Nowak L., Bregestovski P., Ascher P., Herbet A., and Prochiantz A. Magnesium gates glutamate-activated channels in mouse central neurones. Nature 307 (1984) 462-465
248. Nyberg S., Andersson A., Zingmark E., Wahlström G., Bäckström T., and Sundström-Poromaa I. The effect of a low dose of alcohol on allopregnanolone serum concentrations across the menstrual cycle in women with severe premenstrual syndrome and controls. Psychoneuroendocrinology 30 (2005) 892-901
249. Oatridge A., Holdcroft A., Saeed N., Hajnal J.V., Puri B.K., Fusi L., and Bydder G.M. Change in brain size during and after pregnancy: study in healthy women and women with preeclampsia. AJNR Am. J. Neuroradiol. 23 (2002) 19-26
250. Ödmark I.S., Bäckström T., Jonsson B., and Bixo M. Long-term effects of two different continuous combined regimens of hormone replacement therapy on well-being. Gynecol. Endocrinol. 18 (2004) 305-317
251. O'Keefe J., and Dostrovsky J. The hippocampus as a spatial map. Preliminary evidence from unit activity in the freely-moving rat. Brain Res. 34 (1971) 171-175
252. Osterlund M.K., and Hurd Y.L. Acute 17 beta-estradiol treatment down-regulates serotonin 5HT1A receptor mRNA expression in the limbic system of female rats. Brain Res. Mol. Brain Res. 55 (1998) 169-172
253. Osterlund M., Kuiper G.G., Gustafsson J.A., and Hurd Y.L. Differential distribution and regulation of estrogen receptor-alpha and -beta mRNA within the female rat brain. Brain Res. Mol. Brain Res. 54 (1998) 175-180
254. Osterlund M.K., Overstreet D.H., and Hurd Y.L. The flinders sensitive line rats, a genetic model of depression, show abnormal serotonin receptor mRNA expression in the brain that is reversed by 17beta-estradiol. Brain Res. Mol. Brain Res. 74 (1999) 158-166
255. Osterlund M.K., Gustafsson J.A., Keller E., and Hurd Y.L. Estrogen receptor beta (ERbeta) messenger ribonucleic acid (mRNA) expression within the human forebrain: distinct distribution pattern to ERalpha mRNA. J. Clin. Endocrinol. Metab. 85 (2000) 3840-3846
256. Osterlund M.K., Halldin C., and Hurd Y.L. Effects of chronic 17beta-estradiol treatment on the serotonin 5-HT (1A) receptor mRNA and binding levels in the rat brain. Synapse 35 (2000) 39-44
257. Osterlund M.K., Keller E., and Hurd Y.L. The human forebrain has discrete estrogen receptor alpha messenger RNA expression: high levels in the amygdaloid complex. Neuroscience 95 (2000) 333-342
258. Owen G.I., Richer J.K., Tung L., Takimoto G., and Horwitz K.B. Progesterone regulates transcription of the p21 (WAF1) cyclin-dependent kinase inhibitor gene through Sp1 and CBP/p300. J. Biol. Chem. 273 (1998) 10696-10701
259. Paech K., Webb P., Kuiper G.G., Nilsson S., Gustafsson J., Kushner P.J., and Scanlan T.S. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science 277 (1997) 1508-1510
260. Palmer A.A., Moyer M.R., Crabbe J.C., and Phillips T.J. Initial sensitivity, tolerance and cross-tolerance to allopregnanolone- and ethanol-induced hypothermia in selected mouse lines. Psychopharmacology (Berlin) 162 (2002) 313-322
261. Palvimaki E.P., Roth B.L., Majasuo H., Laakso A., Kuoppamaki M., Syvalahti E., and Hietala J. Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptor. Psychopharmacology (Berlin) 126 (1996) 234-240
262. Parks C.L., and Shenk T. The serotonin 1a receptor gene contains a TATA-less promoter that responds to MAZ and Sp1. J. Biol. Chem. 271 (1996) 4417-4430
263. Parks C.L., Robinson P.S., Sibille E., Shenk T., and Toth M. Increased anxiety of mice lacking the serotonin1A receptor. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 10734-10739
264. Paul S.M., and Purdy R.H. Neuroactive steroids. FASEB J. 6 (1992) 2311-2322
265. Pecins-Thompson M., and Bethea C.L. Ovarian steroid regulation of serotonin-1A autoreceptor messenger RNA expression in the dorsal raphe of rhesus macaques. Neuroscience 89 (1999) 267-277
266. Pecins-Thompson M., Brown N.A., Kohama S.G., and Bethea C.L. Ovarian steroid regulation of tryptophan hydroxylase mRNA expression in rhesus macaques. J. Neurosci. 16 (1996) 7021-7029
267. Pecins-Thompson M., Brown N.A., and Bethea C.L. Regulation of serotonin re-uptake transporter mRNA expression by ovarian steroids in rhesus macaques. Brain Res. Mol. Brain Res. 53 (1998) 120-129
268. Peng Z., Hauer B., Mihalek R.M., Homanics G.E., Sieghart W., Olsen R.W., and Houser C.R. GABA (A) receptor changes in delta subunit-deficient mice: altered expression of alpha4 and gamma2 subunits in the forebrain. J. Comp. Neurol. 446 (2002) 179-197
269. Penington N.J., and Kelly J.S. Serotonin receptor activation reduces calcium current in an acutely dissociated adult central neuron. Neuron 4 (1990) 751-758
270. Perrot-Applanat M., Logeat F., Groyer-Picard M.T., and Milgrom E. Immunocytochemical study of mammalian progesterone receptor using monoclonal antibodies. Endocrinology 116 (1985) 1473-1484
271. Pettersson K., Grandien K., Kuiper G.G., and Gustafsson J.A. Mouse estrogen receptor beta forms estrogen response element-binding heterodimers with estrogen receptor alpha. Mol. Endocrinol. 11 (1997) 1486-1496
272. Petz L.N., and Nardulli A.M. Sp1 binding sites and an estrogen response element half-site are involved in regulation of the human progesterone receptor A promoter. Mol. Endocrinol. 14 (2000) 972-985
273. Phillips S.M., and Sherwin B.B. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 17 (1992) 485-495
274. Prendiville S., and Gale K. Anticonvulsant effect of fluoxetine on focally evoked limbic motor seizures in rats. Epilepsia 34 (1993) 381-384
275. Prince R.J., and Simmonds M.A. 5 Beta-pregnan-3 beta-ol-20-one, a specific antagonist at the neurosteroid site of the GABAA receptor-complex. Neurosci. Lett. 135 (1992) 273-275
276. Prince R.J., and Simmonds M.A. Differential antagonism by epipregnanolone of alphaxalone and pregnanolone potentiation of [3H]flunitrazepam binding suggests more than one class of binding site for steroids at GABAA receptors. Neuropharmacology 32 (1993) 59-63
277. Puigserver P., and Spiegelman B.M. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr. Rev. 24 (2003) 78-90
278. Purdy R.H., Moore Jr. P.H., Rao P.N., Hagino N., Yamaguchi T., Schmidt P., Rubinow D.R., Morrow A.L., and Paul S.M. Radioimmunoassay of 3 alpha-hydroxy-5 alpha-pregnan-20-one in rat and human plasma. Steroids 55 (1990) 290-296
279. Purdy R.H., Morrow A.L., Moore Jr. P.H., and Paul S.M. Stress-induced elevations of gamma-aminobutyric acid type A receptor-active steroids in the rat brain. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 4553-4557
280. Rapkin A.J., Morgan M., Goldman L., Brann D.W., Simone D., and Mahesh V.B. Progesterone metabolite allopregnanolone in women with premenstrual syndrome. Obstet. Gynecol. 90 (1997) 709-714
281. Rebar R.W., Trabal J., and Mortola J. Low-dose esterified estrogens (0.3 mg/day): long-term and short-term effects on menopausal symptoms and quality of life in postmenopausal women. Climacteric 3 (2000) 176-182
282. Reddy D.S., and Kulkarni S.K. The effects of neurosteroids on acquisition and retention of a modified passive-avoidance learning task in mice. Brain Res. 791 (1998) 108-116
283. Redish A.D. The hippocampal debate: are we asking the right questions?. Behav. Brain Res. 127 (2001) 81-98
284. Register T.C., Shively C.A., and Lewis C.E. Expression of estrogen receptor alpha and beta transcripts in female monkey hippocampus and hypothalamus. Brain Res. 788 (1998) 320-322
285. Renner K.J., Krey L.C., and Luine V.N. Effect of progesterone on monoamine turnover in the brain of the estrogen-primed rat. Brain Res. Bull. 19 (1987) 195-202
286. Ressler K.J., and Nemeroff C.B. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress. Anxiety 12 Suppl. 1 (2000) 2-19
287. Richter-Levin G., and Segal M. Age-related cognitive deficits in rats are associated with a combined loss of cholinergic and serotonergic functions. Ann. N. Y. Acad. Sci. 695 (1993) 254-257
288. Riedel G., Micheau J., Lam A.G., Roloff E., Martin S.J., Bridge H., Hoz L., Poeschel B., McCulloch J., and Morris R.G. Reversible neural inactivation reveals hippocampal participation in several memory processes. Nat. Neurosci. 2 (1999) 898-905
289. Riedel G., Platt B., and Micheau J. Glutamate receptor function in learning and memory. Behav. Brain Res. 140 (2003) 1-47
290. Riggs B.L., Khosla S., and Melton III L.J. Sex steroids and the construction and conservation of the adult skeleton. Endocr. Rev. 23 (2002) 279-302
291. Robinson R.T., Drafts B.C., and Fisher J.L. Fluoxetine increases GABA (A) receptor activity through a novel modulatory site. J. Pharmacol. Exp. Ther. 304 (2003) 978-984
292. Rolls E.T. Spatial view cells and the representation of place in the primate hippocampus. Hippocampus 9 (1999) 467-480
293. Ruat M., Traiffort E., Leurs R., Tardivel-Lacombe J., Diaz J., Arrang J.M., and Schwartz J.C. Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 8547-8551
294. Rudolph U., Crestani F., Benke D., Brunig I., Benson J.A., Fritschy J.M., Martin J.R., Bluethmann H., and Mohler H. Benzodiazepine actions mediated by specific gamma-aminobutyric acid (A) receptor subtypes. Nature 401 (1999) 796-800
295. Ruff M., Gangloff M., Wurtz J.M., and Moras D. Estrogen receptor transcription and transactivation: Structure-function relationship in DNA- and ligand-binding domains of estrogen receptors. Breast Cancer Res. 2 (2000) 353-359
296. Sanacora G., Mason G.F., Rothman D.L., Behar K.L., Hyder F., Petroff O.A., Berman R.M., Charney D.S., and Krystal J.H. Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch. Gen. Psychiatry 56 (1999) 1043-1047
297. Sanacora G., Mason G.F., Rothman D.L., and Krystal J.H. Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. Am. J. Psychiatry 159 (2002) 663-665
298. Sarnyai Z., Sibille E.L., Pavlides C., Fenster R.J., McEwen B.S., and Toth M. Impaired hippocampal-dependent learning and functional abnormalities in the hippocampus in mice lacking serotonin (1A) receptors. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 14731-14736
299. Sarter M.F., and Bruno J.P. Cognitive functions of cortical ACh: lessons from studies on trans-synaptic modulation of activated efflux. Trends Neurosci. 17 (1994) 217-221
300. Sassoe-Pognetto M., Panzanelli P., Sieghart W., and Fritschy J.M. Colocalization of multiple GABA (A) receptor subtypes with gephyrin at postsynaptic sites. J. Comp. Neurol. 420 (2000) 481-498
301. Schmidt P.J., Purdy R.H., Moore Jr. P.H., Paul S.M., and Rubinow D.R. Circulating levels of anxiolytic steroids in the luteal phase in women with premenstrual syndrome and in control subjects. J. Clin. Endocrinol. Metab. 79 (1994) 1256-1260
302. Schmidt P.J., Nieman L., Danaceau M.A., Tobin M.B., Roca C.A., Murphy J.H., and Rubinow D.R. Estrogen replacement in perimenopause-related depression: a preliminary report. Am. J. Obstet. Gynecol. 183 (2000) 414-420
303. Schneider L.S., Small G.W., Hamilton S.H., Bystritsky A., Nemeroff C.B., and Meyers B.S. Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Fluoxetine Collaborative Study Group. Am. J. Geriatr. Psychiatry 5 (1997) 97-106
304. Seippel L., and Backstrom T. Luteal-phase estradiol relates to symptom severity in patients with premenstrual syndrome. J. Clin. Endocrinol. Metab. 83 (1998) 1988-1992
305. Serra M., Pisu M.G., Littera M., Papi G., Sanna E., Tuveri F., Usala L., Purdy R.H., and Biggio G. Social isolation-induced decreases in both the abundance of neuroactive steroids and GABA (A) receptor function in rat brain. J. Neurochem. 75 (2000) 732-740
306. Shen H., Gong Q.H., Yuan M., and Smith S.S. Short-term steroid treatment increases delta GABAA receptor subunit expression in rat CA1 hippocampus: pharmacological and behavioral effects. Neuropharmacology 49 (2005) 573-586
307. Sherwin B.B., and Tulandi T. "Add-back" estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with leiomyomata uteri. J. Clin. Endocrinol. Metab. 81 (1996) 2545-2549
308. Shively C.A., Mirkes S.J., Lu N.Z., Henderson J.A., and Bethea C.L. Soy and social stress affect serotonin neurotransmission in primates. Pharmacogenomics J. 3 (2003) 114-121
309. Shughrue P.J., Lane M.V., and Merchenthaler I. Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system. J. Comp. Neurol. 388 (1997) 507-525
310. Shughrue P.J., Lane M.V., Scrimo P.J., and Merchenthaler I. Comparative distribution of estrogen receptor-alpha (ER-alpha) and beta (ER-beta) mRNA in the rat pituitary, gonad, and reproductive tract. Steroids 63 (1998) 498-504
311. Shumaker S.A., Legault C., Rapp S.R., Thal L., Wallace R.B., Ockene J.K., Hendrix S.L., Jones III B.N., Assaf A.R., Jackson R.D., Kotchen J.M., Wassertheil-Smoller S., and Wactawski-Wende J. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 289 (2003) 2651-2662
312. Sibille E., Pavlides C., Benke D., and Toth M. Genetic inactivation of the Serotonin (1A) receptor in mice results in downregulation of major GABA (A) receptor alpha subunits, reduction of GABA (A) receptor binding, and benzodiazepine-resistant anxiety. J. Neurosci. 20 (2000) 2758-2765
313. Smith S.S. Estrogen administration increases neuronal responses to excitatory amino acids as a long-term effect. Brain Res. 503 (1989) 354-357
314. Smith S.S., Gong Q.H., Hsu F.C., Markowitz R.S., ffrench-Mullen J.M., and Li X. GABA (A) receptor alpha4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature 392 (1998) 926-930
315. Smith S.S., Gong Q.H., Li X., Moran M.H., Bitran D., Frye C.A., and Hsu F.C. Withdrawal from 3alpha-OH-5alpha-pregnan-20-One using a pseudopregnancy model alters the kinetics of hippocampal GABAA-gated current and increases the GABAA receptor alpha4 subunit in association with increased anxiety. J. Neurosci. 18 (1998) 5275-5284
316. Soderpalm B., Andersson G., Enerback C., and Engel J.A. In vivo administration of the 5-HT1A receptor agonist 8-OH-DPAT interferes with brain GABA (A)/benzodiazepine receptor complexes. Neuropharmacology 36 (1997) 1071-1077
317. Speroff L., Glass R.H., and Kase N.G. Clinical Gynecologic Edocrinology and Infertility. 6th ed. In: Mitchell C. (Ed) (1999), Lippincott Williams and Wilkins
318. Srivastava S., Weitzmann M.N., Kimble R.B., Rizzo M., Zahner M., Milbrandt J., Ross F.P., and Pacifici R. Estrogen blocks M-CSF gene expression and osteoclast formation by regulating phosphorylation of Egr-1 and its interaction with Sp-1. J. Clin. Invest. 102 (1998) 1850-1859
319. Staley K.J., and Mody I. Shunting of excitatory input to dentate gyrus granule cells by a depolarizing GABAA receptor-mediated postsynaptic conductance. J. Neurophysiol. 68 (1992) 197-212
320. Stell B.M., Brickley S.G., Tang C.Y., Farrant M., and Mody I. Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by delta subunit-containing GABAA receptors. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 14439-14444
321. Strohle A., Romeo E., di Michele F., Pasini A., Hermann B., Gajewsky G., Holsboer F., and Rupprecht R. Induced panic attacks shift gamma-aminobutyric acid type A receptor modulatory neuroactive steroid composition in patients with panic disorder: preliminary results. Arch. Gen. Psychiatry 60 (2003) 161-168
322. Strömberg J., Bäckström T., and Lundgren P. Rapid non-genomic effect of glucocorticoid metabolites and neurosteroids on the gamma-aminobutyric acid-A receptor. Eur. J. Neurosci. 21 (2005) 2083-2088
323. Struder H.K., and Weicker H. Physiology and pathophysiology of the serotonergic system and its implications on mental and physical performance: Part I. Int. J. Sports Med. 22 (2001) 467-481
324. Summer B.E., and Fink G. Estrogen increases the density of 5-hydroxytryptamine (2A) receptors in cerebral cortex and nucleus accumbens in the female rat. J. Steroid Biochem. Mol. Biol. 54 (1995) 15-20
325. Sumner B.E., and Fink G. Effects of acute estradiol on 5-hydroxytryptamine and dopamine receptor subtype mRNA expression in female rat brain. Mol. Cell. Neurosci. 4 (1993) 83-92
326. Sumner B.E., and Fink G. Testosterone as well as estrogen increases serotonin2A receptor mRNA and binding site densities in the male rat brain. Brain Res. Mol. Brain Res. 59 (1998) 205-214
327. Sumner B.E., Grant K.E., Rosie R., Hegele-Hartung C., Fritzemeier K.H., and Fink G. Effects of tamoxifen on serotonin transporter and 5-hydroxytryptamine (2A) receptor binding sites and mRNA levels in the brain of ovariectomized rats with or without acute estradiol replacement. Brain Res. Mol. Brain Res. 73 (1999) 119-128
328. Sundstrom I., and Backstrom T. Citalopram increases pregnanolone sensitivity in patients with premenstrual syndrome: an open trial. Psychoneuroendocrinology 23 (1998) 73-88
329. Sundstrom I., Ashbrook D., and Backstrom T. Reduced benzodiazepine sensitivity in patients with premenstrual syndrome: a pilot study. Psychoneuroendocrinology 22 (1997) 25-38
330. Sundstrom I., Andersson A., Nyberg S., Ashbrook D., Purdy R.H., and Backstrom T. Patients with premenstrual syndrome have a different sensitivity to a neuroactive steroid during the menstrual cycle compared to control subjects. Neuroendocrinology 67 (1998) 126-138
331. Sundstrom I., Backstrom T., Wang M., Olsson T., Seippel L., and Bixo M. Premenstrual syndrome, neuroactive steroids and the brain. Gynecol. Endocrinol. 13 (1999) 206-220
332. Sundstrom I., Spigset O., Andersson A., Appelblad P., and Backstrom T. Lack of influence of menstrual cycle and premenstrual syndrome diagnosis on pregnanolone pharmacokinetics. Eur. J. Clin. Pharmacol. 55 (1999) 125-130
333. Sutton J. The Stanford Encyclopedia of Philosophy (2003), Zalta, E.N.
334. Tcherepanova I., Puigserver P., Norris J.D., Spiegelman B.M., and McDonnell D.P. Modulation of estrogen receptor-alpha transcriptional activity by the coactivator PGC-1. J. Biol. Chem. 275 (2000) 16302-16308
335. Teng E., and Squire L.R. Memory for places learned long ago is intact after hippocampal damage. Nature 400 (1999) 675-677
336. Thomas D.R., and Hagan J.J. 5-HT7 receptors. Curr. Drug. Targets. CNS. Neurol. Disord. 3 (2004) 81-90
337. Tietz E.I., Huang X., Chen S., and Ferencak III W.F. Temporal and regional regulation of alpha1, beta2 and beta3, but not alpha2, alpha4, alpha5, alpha6, beta1 or gamma2 GABA (A) receptor subunit messenger RNAs following one-week oral flurazepam administration. Neuroscience 91 (1999) 327-341
338. Toth M. 5-HT1A receptor knockout mouse as a genetic model of anxiety. Eur. J. Pharmacol. 463 (2003) 177-184
339. Toufexis D.J., Davis C., Hammond A., and Davis M. Progesterone attenuates corticotropin-releasing factor-enhanced but not fear-potentiated startle via the activity of its neuroactive metabolite, allopregnanolone. J. Neurosci. 24 (2004) 10280-10287
340. Tsien J.Z., Huerta P.T., and Tonegawa S. The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory. Cell 87 (1996) 1327-1338
341. Tunnicliff G., Schindler N.L., Crites G.J., Goldenberg R., Yochum A., and Malatynska E. The GABA (A) receptor complex as a target for fluoxetine action. Neurochem. Res. 24 (1999) 1271-1276
342. Turgeon J.L., McDonnell D.P., Martin K.A., and Wise P.M. Hormone therapy: physiological complexity belies therapeutic simplicity. Science 304 (2004) 1269-1273
343. Turkmen S., Lundgren P., Birzniece V., Zingmark E., Backstrom T., and Johansson I.M. 3Beta-20beta-dihydroxy-5alpha-pregnane (UC1011) antagonism of the GABA potentiation and the learning impairment induced in rats by allopregnanolone. Eur J. Neurosci. 20 (2004) 1604-1612
344. Uzunov D.P., Cooper T.B., Costa E., and Guidotti A. Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 12599-12604
345. Uzunova V., Sheline Y., Davis J.M., Rasmusson A., Uzunov D.P., Costa E., and Guidotti A. Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 3239-3244
346. Vallee M., Mayo W., Koob G.F., and Le Moal M. Neurosteroids in learning and memory processes. Int. Rev. Neurobiol. 46 (2001) 273-320
347. Vallee M., Mayo W., and Le Moal M. Role of pregnenolone, dehydroepiandrosterone and their sulfate esters on learning and memory in cognitive aging. Brain Res. Brain Res. Rev. 37 (2001) 301-312
348. van Broekhoven F., and Verkes R.J. Neurosteroids in depression: a review. Psychopharmacology (Berlin) 165 (2003) 97-110
349. Van de Kar L.D. Neuroendocrine pharmacology of serotonergic (5-HT) neurons. Annu. Rev. Pharmacol. Toxicol. 31 (1991) 289-320
350. Van Oekelen D., Luyten W.H., and Leysen J.E. 5-HT2A and 5-HT2C receptors and their atypical regulation properties. Life Sci. 72 (2003) 2429-2449
351. Vaswani M., Linda F.K., and Ramesh S. Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review. Prog. Neuro-psychopharmacol. Biol. Psychiatry 27 (2003) 85-102
352. Walter P., Green S., Greene G., Krust A., Bornert J.M., Jeltsch J.M., Staub A., Jensen E., Scrace G., Waterfield M., et al. Cloning of the human estrogen receptor cDNA. Proc. Natl. Acad. Sci. U. S. A. 82 (1985) 7889-7893
353. Wang M., Seippel L., Purdy R.H., and Backstrom T. Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulfate, 5 alpha-pregnane-3,20-dione and 3 alpha-hydroxy-5 alpha-pregnan-20-one. J. Clin. Endocrinol. Metab. 81 (1996) 1076-1082
354. Wang M.D., Backstrom T., and Landgren S. The inhibitory effects of allopregnanolone and pregnanolone on the population spike, evoked in the rat hippocampal CA1 stratum pyramidale in vitro, can be blocked selectively by epiallopregnanolone. Acta. Physiol. Scand. 169 (2000) 333-341
355. Wang J., Green P.S., and Simpkins J.W. Estradiol protects against ATP depletion, mitochondrial membrane potential decline and the generation of reactive oxygen species induced by 3-nitroproprionic acid in SK-N-SH human neuroblastoma cells. J. Neurochem. 77 (2001) 804-811
356. Wang M., He Y., Eisenman L.N., Fields C., Zeng C.M., Mathews J., Benz A., Fu T., Zorumski E., Steinbach J.H., Covey D.F., Zorumski C.F., and Mennerick S. 3Beta-hydroxypregnane steroids are pregnenolone sulfate-like GABA (A) receptor antagonists. J. Neurosci. 22 (2002) 3366-3375
357. Warren S.G., Humphreys A.G., Juraska J.M., and Greenough W.T. LTP varies across the estrous cycle: enhanced synaptic plasticity in proestrus rats. Brain Res. 703 (1995) 26-30
358. Wei H., Xiong W., Yang S., Zhou Q., Liang C., Zeng B.X., and Xu L. Propofol facilitates the development of long-term depression (LTD) and impairs the maintenance of long-term potentiation (LTP) in the CA1 region of the hippocampus of anesthetized rats. Neurosci. Lett. 324 (2002) 181-184
359. Weigel N.L. Steroid hormone receptors and their regulation by phosphorylation. Biochem. J. 319 (1996) 657-667
360. Weiland N.G. Estradiol selectively regulates agonist binding sites on the N-methyl-d-aspartate receptor complex in the CA1 region of the hippocampus. Endocrinology 131 (1992) 662-668
361. Weiland N.G., Orikasa C., Hayashi S., and McEwen B.S. Distribution and hormone regulation of estrogen receptor immunoreactive cells in the hippocampus of male and female rats. J. Comp. Neurol. 388 (1997) 603-612
362. Weir C.J., Ling A.T., Belelli D., Wildsmith J.A., Peters J.A., and Lambert J.J. The interaction of anaesthetic steroids with recombinant glycine and GABAA receptors. Br. J. Anaesth. 92 (2004) 704-711
363. Westlund Tam L., and Parry B.L. Does estrogen enhance the antidepressant effects of fluoxetine?. J. Affect. Disord. 77 (2003) 87-92
364. Whatley V.J., Brozowski S.J., Hadingham K.L., Whiting P.J., and Harris R.A. Microtubule depolymerization inhibits ethanol-induced enhancement of GABAA responses in stably transfected cells. J. Neurochem. 66 (1996) 1318-1321
365. Wikander I., Sundblad C., Andersch B., Dagnell I., Zylberstein D., Bengtsson F., and Eriksson E. Citalopram in premenstrual dysphoria: is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle?. J. Clin. Psychopharmacol. 18 (1998) 390-398
366. Willins D.L., Deutch A.Y., and Roth B.L. Serotonin 5-HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex. Synapse 27 (1997) 79-82
367. Wisden W., Laurie D.J., Monyer H., and Seeburg P.H. The distribution of 13 GABAA receptor subunit mRNAs in the rat brain: I. Telencephalon, diencephalon, mesencephalon. J. Neurosci. 12 (1992) 1040-1062
368. Wise P.M. Estrogens and neuroprotection. Trends Endocrinol. Metab. 13 (2002) 229-230
369. Wissink S., Meijer O., Pearce D., van Der Burg B., and van Der Saag P.T. Regulation of the rat serotonin-1A receptor gene by corticosteroids. J. Biol. Chem. 275 (2000) 1321-1326
370. Wolff M., Savova M., Malleret G., Hen R., Segu L., and Buhot M.C. Serotonin 1B knockout mice exhibit a task-dependent selective learning facilitation. Neurosci. Lett. 338 (2003) 1-4
371. Woolley C.S., and McEwen B.S. Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat. J. Neurosci. 12 (1992) 2549-2554
372. Woolley C.S., and McEwen B.S. Estradiol regulates hippocampal dendritic spine density via an N-methyl-d-aspartate receptor-dependent mechanism. J. Neurosci. 14 (1994) 7680-7687
373. Yu R., Follesa P., and Ticku M.K. Down-regulation of the GABA receptor subunits mRNA levels in mammalian cultured cortical neurons following chronic neurosteroid treatment. Brain Res. Mol. Brain Res. 41 (1996) 163-168
374. Zhao T.J., Chiu T.H., and Rosenberg H.C. Decreased expression of gamma-aminobutyric acid type A/benzodiazepine receptor beta subunit mRNAs in brain of flurazepam-tolerant rats. J. Mol. Neurosci. 5 (1994) 181-192
375. Zhou W., Cunningham K.A., and Thomas M.L. Estrogen regulation of gene expression in the brain: a possible mechanism altering the response to psychostimulants in female rats. Brain Res. Mol. Brain Res. 100 (2002) 75-83
376. Zhou W., Koldzic-Zivanovic N., Clarke C.H., de Beun R., Wassermann K., Bury P.S., Cunningham K.A., and Thomas M.L. Selective estrogen receptor modulator effects in the rat brain. Neuroendocrinology 75 (2002) 24-33
377. Zhu Q.S., Chen K., and Shih J.C. Characterization of the human 5-HT2A receptor gene promoter. J. Neurosci. 15 (1995) 4885-4895
378. Zhu D., Wang M.D., Backstrom T., and Wahlstrom G. Evaluation and comparison of the pharmacokinetic and pharmacodynamic properties of allopregnanolone and pregnanolone at induction of anaesthesia in the male rat. Br. J. Anaesth. 86 (2001) 403-412
379. Zhu D., Birzniece V., Backstrom T., and Wahlstrom G. Dynamic aspects of acute tolerance to allopregnanolone evaluated using anaesthesia threshold in male rats. Br. J. Anaesth. 93 (2004) 560-567
380. Zweifel J.E., and O'Brien W.H. A meta-analysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrinology 22 (1997) 189-212